×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANIP – ani pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANIP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/18
10:52 am
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
12/15
01:21 pm
anip
Gastroparesis Drugs Market size to increase by USD 1.42 Billion between 2023 to 2028, Market Segmentation by Drug Class, Disease Type, Geography, Technavio [Yahoo! Finance]
Low
Report
Gastroparesis Drugs Market size to increase by USD 1.42 Billion between 2023 to 2028, Market Segmentation by Drug Class, Disease Type, Geography, Technavio [Yahoo! Finance]
12/12
07:05 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
12/11
08:01 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $80.00 price target on the stock.
Low
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $80.00 price target on the stock.
12/2
03:48 pm
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
11/27
03:15 pm
anip
Here's Why Retaining Cigna Stock is a Smart Move for Investors Now [Yahoo! Finance]
Low
Report
Here's Why Retaining Cigna Stock is a Smart Move for Investors Now [Yahoo! Finance]
11/26
04:30 pm
anip
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
Low
Report
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
11/26
12:03 pm
anip
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? [Yahoo! Finance]
Low
Report
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
05:59 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 17 Filed by: CAREY STEPHEN P.
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 17 Filed by: CAREY STEPHEN P.
12/17
05:35 pm
anip
Form 144 ANI PHARMACEUTICALS INC Filed by: CAREY STEPHEN P.
Medium
Report
Form 144 ANI PHARMACEUTICALS INC Filed by: CAREY STEPHEN P.
12/16
04:20 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 13 Filed by: Cook Meredith
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 13 Filed by: Cook Meredith
12/12
05:09 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 11 Filed by: Davis Krista
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 11 Filed by: Davis Krista
11/27
05:39 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Nov 26 Filed by: Lalwani Nikhil
Medium
Report
Form 4 ANI PHARMACEUTICALS INC For: Nov 26 Filed by: Lalwani Nikhil
11/26
07:44 pm
anip
Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil
Low
Report
Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil
11/20
07:01 am
anip
Form 8-K ANI PHARMACEUTICALS INC For: Nov 20
Low
Report
Form 8-K ANI PHARMACEUTICALS INC For: Nov 20
11/18
04:06 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Nov 15 Filed by: Rowland Thomas Andrew
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Nov 15 Filed by: Rowland Thomas Andrew
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
18.7%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
TOP News Decliners
11/6
Q3/2019 9/30/2019 EPS 1.230 ZacksConsensus 1.320 ActVsEst (0.090) - Miss
-23.7%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: